Evidence map›Paper›PMID 37604821›Full record

ArticleNature communications2023

At-home wearables and machine learning sensitively capture disease progression in amyotrophic lateral sclerosis.

Anoopum S Gupta, Siddharth Patel, Alan Premasiri, Fernando Vieira

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06885918 (ALS Translational Research Program), which is not on this map. Cited by 37 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 3 pooled it
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06885918 recruitingnot on this map

ALS Translational Research Program

TypeobservationalSponsorALS Therapy Development InstituteRan2014 to 2035Enrolled2,000ConditionsAmyotrophic Lateral Sclerosis, ALS (Amyotrophic Lateral Sclerosis), ALS With Frontotemporal Dementia (ALS/FTD), Motor Neuron Disease
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 3 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Digital Outcomes as Biomarkers of Disease Progression in Early Parkinson's Disease: A Systematic Review.Movement disorders : official journal of the Movement Disorder Society · 2025
    Pooled it
  3. Pooled it
  4. Observational
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Contrastive Learning Model for Wearable-Based Ataxia Assessment.IEEE transactions on bio-medical engineering · 2026
    Article
  10. Article
  11. Advancing Wearable-Based Upper-Limb Stroke Recovery Assessment to the Clinic: A Comparison of Movement Segmentation Strategies.IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Digital Activity Markers in Chronic Inflammatory Demyelinating Polyneuropathy.Annals of clinical and translational neurology · 2025
    Observational
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Anoopum S GuptaDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. agupta@mgh.harvard.edu.ORCID http://orcid.org/0000-0002-8741-0621
Siddharth PatelDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0009-0000-9493-1815
Alan PremasiriALS Therapy Development Institute, Watertown, MA, USA.ORCID http://orcid.org/0000-0002-0261-9953
Fernando VieiraALS Therapy Development Institute, Watertown, MA, USA.ORCID http://orcid.org/0000-0003-2996-6418
Amyotrophic Lateral Sclerosis Therapy Development Institute · USHarvard University · US

Funding

A Computational Approach for Quantifying Motor Behaviors in Spinocerebellar Ataxias to Improve Early Detection of Motor Signs and Precisely Estimate Disease Severity and Disease ChangeR01NS117826 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI GUPTA, ANOOPUM SATYAWAN · 2021 to 2025
$2.7M
NINDS NIH HHS R01 NS117826
6 · The paper itself

Abstract

Amyotrophic lateral sclerosis causes degeneration of motor neurons, resulting in progressive muscle weakness and impairment in motor function. Promising drug development efforts have accelerated in amyotrophic lateral sclerosis, but are constrained by a lack of objective, sensitive, and accessible outcome measures. Here we investigate the use of wearable sensors, worn on four limbs at home during natural behavior, to quantify motor function and disease progression in 376 individuals with amyotrophic lateral sclerosis. We use an analysis approach that automatically detects and characterizes submovements from passively collected accelerometer data and produces a machine-learned severity score for each limb that is independent of clinical ratings. We show that this approach produces scores that progress faster than the gold standard Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (-0.86 ± 0.70 SD/year versus -0.73 ± 0.74 SD/year), resulting in smaller clinical trial sample size estimates (N = 76 versus N = 121). This method offers an ecologically valid and scalable measure for potential use in amyotrophic lateral sclerosis trials and clinical care.

Indexed as

Amyotrophic Lateral SclerosisWearable Electronic DevicesDisease ProgressionHumansMachine LearningMotor Neurons

Identifiers

PMID37604821
PMCPMC10442344
OpenAlexW4386022403

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.